OxySure Systems (OXYS) Appoints PP Aviation Corp. as Military Drone Distributor
Frisco, TX, July 23, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (OxySure, or the Company), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology, today announced the appointment of PP Aviation Corporation (PPA) as a non-exclusive distributor of its medical drones into military markets.
PPA is experienced in the business of promoting and selling military products and oxygen equipment for military and aviation applications, including the US Army, US Air Force, US Navy, US Marines, Green Berets, Special Operations forces, and other military organizations and Foreign Military Sales.
Commented Tom Przybyla, President of PPA: “We are eager to get started with the OxySure drone platform for medical applications and our military customers have expressed strong interest. We look forward to expanding our relationship with OxySure to include the exciting opportunities presented by the drone era and more specifically as it relates to medical emergency and combat situations.”
“We have a long history with PPA and the drone distribution agreement with PPA makes logical sense,” stated Julian Ross, CEO of OxySure. “We are taking those steps needed to be ready to effectively present our solutions to our customers as we await our regulatory approval for commercial drone usage.”
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from two dry, inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
OxySure Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Redchip Companies, Inc.
Jon Cunningham: jon@redchip.com
800-733-2447, ext. 107 | www.redchip.com/
Tags: